Capital International Investors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $4.41M | Sell |
|
|||||
|
2021
Q4 | $4.9M | Sell |
|
|||||
|
2021
Q3 | $42.9M | Sell |
|
|||||
|
2021
Q2 | $109M | Sell |
|
|||||
|
2021
Q1 | $153M | Sell |
|
|||||
|
2020
Q4 | $327M | Sell |
|
|||||
|
2020
Q3 | $411M | Sell |
|
|||||
|
2020
Q2 | $744M | Buy |
|
|||||
|
2020
Q1 | $521M | Buy |
|
|||||
|
2019
Q4 | $627M | Buy |
|
|||||
|
2019
Q3 | $525M | Buy |
|
|||||
|
2019
Q2 | $475M | Buy |
|
|||||
|
2019
Q1 | $390M | Buy |
|
|||||
|
2018
Q4 | $252M | Buy |
|
|||||
|
2018
Q3 | $31.7M | Buy |
|